CHINA GEWANG BIOTECHNOLOGY, INC. - Statements of Cash Flows - USD ($)	6 Months Ended
	May. 31, 2015	May. 31, 2014
Cash flows from Operating Activities
Net income	$ 708,917	$ 320,366
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	13,915	12,925
Changes in operating assets and liabilities:
(Increase) in accounts receivable	(222,905)
(Increase) in inventory	(46,444)	(13,520)
(Increase) in prepaid expenses	(35,401)	(82,483)
(Decrease) increase in advances from customers	(56,930)	8,643
(Decrease) in accounts payable	(7,225)
Increase in taxes payable	13,908	29,486
Increase in payroll payable	48,990
Increase in accrued liabilities and other payables	26,063	328
Net cash provided by operating activities	442,888	275,745
Cash flows from investing activities:
Purchase of equipment	(24,550)
Cash Flows From Financing Activities:
Proceeds from stockholder loans	38,106
Effect of exchange rate changes on cash	5,558	(17,205)
Net change in cash	462,002	258,540
Cash, Beginning of Period	3,012,812	2,289,218
Cash, End of Period	$ 3,474,814	$ 2,547,758
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash paid income taxes	$ 229,218	$ 79,124
Noncash financing activities:
Payment of accrued expenses and other payables by shareholder	$ 40,797